Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF), a Canada-based clinical-stage biotechnology company, announced on Thursday that it has named Sid Taubenfeld as its chief operating officer.

Taubenfeld is a seasoned executive with healthcare and biotech expertise. He has more than 20 years of significant experience in senior leadership roles and a deep understanding of scientific, financial, and commercial strategy. He has held the position of the CEO of Tikun Olam Pharma (TOP). He has extensive pharmaceutical experience in various executive management roles in the United States and Israel.

Taubenfeld holds a BS in Pharmacy from Brooklyn College of Pharmacy and completed his graduate studies at New York Medical College in the area of Pharmacology.